![](/img/cover-not-exists.png)
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4
Jack W Coburn, Hla M Maung, Logan Elangovan, Michael J Germain, Jill S Lindberg, Stuart M Sprague, Mark E Williams, Charles W BishopVolume:
43
Year:
2004
Language:
english
Pages:
14
DOI:
10.1053/j.ajkd.2004.01.012
File:
PDF, 162 KB
english, 2004